Hongjun Gao - Concepedia

Author

Hongjun Gao

Academy of Military Medical Sciences ORCID

Also Known As

H Gao, H. Gao, H.-F. Gao, HONGJUN GAO, Haoxian Gao, Hong-Jun Gao, Hong-jun Gao, HongJun Gao, Hongjun Gao, Hong‐Jun Gao

110

Publications

Citations

H-Index

Concepts

All Affiliations

Academy of Military Medical Sciences Peking University Chinese Academy of Medical Sciences & Peking Union Medical College Chinese PLA General Hospital Peking University Cancer Hospital

About

Hongjun Gao is an author at Academy of Military Medical Sciences specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	881
2	Cell Biology	6	6	163
3	Health Sciences	3	3	132
4	Engineering	1	1	129
5	Biomedical Engineering	1	1	129

Hongjun Gao

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial Zhijie Wang, Ying Cheng, Tongtong An, The Lancet Respiratory Medicine OncologyTumour DnaMedicinePathologyAdvanced Lung Adenocarcinoma	2018	214
Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail Libo Zhao, Chuanhao Tang, Xu Li, Small Multiple Aptamer CombinationsEngineeringCtc CountsCirculating Tumor CellsAnalytical Microsystems	2016	129
miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features Yuanzhuo Gu, Xiyang Wei, Yulin Sun, Cancer Research	2018	95
Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling Mingxiang Ye, Yong Zhang, Hongjun Gao, Clinical Cancer Research	2017	79
A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients Yi Liu, Bing Liu, Xiaoyan Li, Journal of Experimental & Clinical Cancer Research	2011	65
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial Caicun Zhou, Gongyan Chen, Yunchao Huang, Journal of Thoracic Oncology Advanced Nonsquamous NsclcOncologyCamrelizumab Plus CarboplatinMedicineClinical Trials	2023	65
New advances in immunotherapy for non-small cell lung cancer. Haifeng Qin, Fang Wang, Hui Liu, PubMed Tumor ImmunologyNew AdvancesSurgery TherapyMedicineImmunology	2018	55
Prognostic value of baseline hemoglobin‐to‐red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis Shaoxing Yang, Xiuhua Tang, Wenjing Liu, Thoracic Cancer	2020	55
Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells Shaoxing Yang, Jian Cui, Yingshun Yang, Gene PathologyCell DeathCell ProliferationMalignant ProliferationCancer Biology	2015	52
Chronic alcohol exposure promotes HCC stemness and metastasis through β-catenin/miR-22-3p/TET2 axis Danlei Chen, Yan Yan, Xinyi Wang, Aging	2021	51

Page 1